- $183.76m
- $219.32m
- $273.45m
- 89
- 69
- 62
- 86
2019 December 28th | R2021 January 2nd | 2022 December 31st | 2022 January 1st | 2023 December 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 252 | 198 | 279 | 247 | 273 |
Cost of Revenue | |||||
Gross Profit | 61.9 | 48.1 | 58.6 | 56.8 | 65 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 234 | 184 | 265 | 229 | 258 |
Operating Profit | 17.5 | 13.5 | 14.2 | 17.4 | 15.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 16.2 | 13.2 | 14.4 | 19.1 | 11 |
Provision for Income Taxes | |||||
Net Income After Taxes | 13.3 | 11 | 11.1 | 16.2 | 8.59 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 13.3 | 5.41 | 12.3 | 9.35 | 8.59 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 13.3 | 5.41 | 12.3 | 9.35 | 8.59 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.46 | 2.04 | 1.86 | 2.83 | 1.37 |
Dividends per Share |